Physician profile
Mena Morgan
NPI 1194175737
$1,068.03
in general payments reported to CMS, 2019-2025
7 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.64 · 2020: $63.74 · 2023: $181 · 2024: $573 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508 · Travel and Lodging: $294 · Gift: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.21 |
| Travel and Lodging | $294.19 |
| Gift | $110.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $706.55 | 2019-2025 | Invisalign, Invisalign First - Comprehensive, Invisalign First - Comprehensive Phase 2 |
| Ormco Corporation | $157.44 | 2019-2023 | Spark |
| Purelife, LLC | $100.00 | 2025 | |
| Envista Holdings Corporation | $45.20 | 2025 | Spark, Vector Tas |
| Nobel Biocare USA | $31.06 | 2023 | Nobelactive |
| Solventum Corporation | $14.20 | 2024 | Apc II Unitek Gemini |
| American Orthodontics Corporation | $13.58 | 2024 | LP and Ifit Tubes, Master Series, Radiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mena Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.